# Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study

> **NCT05184478** · PHASE1,PHASE2 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Tourette Syndrome in Adolescence

## Interventions

- **DRUG:** Medicinal cannabis (MC): THC 10mg/mL : CBD 15mg/mL, manufactured by Cann Group Ltd.
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05184478
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-16
- **Primary completion:** 2023-12-05
- **Final completion:** 2024-01-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05184478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05184478, "Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05184478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*